HT
EDIT icon

HAP Trading’s Editas Medicine EDIT Stock Holding History

HAP Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-36,831
Closed -$494K – 2042
2022
Q1 		$701K Buy
36,831
+11,045
+43% +$205K 0.03% 441
2021
Q4 		$685K Sell
25,786
-2,482
-9% -$85.4K 0.02% 589
2021
Q3 		$1.16M Buy
+28,268
New +$1.55M 0.04% 427
2021
Q2 		– Sell
-24,083
Closed -$890K – 2437
2021
Q1 		$1.01M Buy
24,083
+12,158
+102% +$693K 0.05% 324
2020
Q4 		$836K Buy
+11,925
New +$490K 0.02% 468
2020
Q2 		– Sell
-11,945
Closed -$312K – 1741
2020
Q1 		$237K Buy
+11,945
New +$301K 0.02% 503
2019
Q4 		– Sell
-10,411
Closed -$260K – 1290
2019
Q3 		$237K Sell
10,411
-7,426
-42% -$184K 0.02% 454
2019
Q2 		$441K Sell
17,837
-9,680
-35% -$231K 0.03% 355
2019
Q1 		$673K Buy
+27,517
New +$623K 0.06% 238

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

HAP Trading's EDIT Position: Q2 2022 in Review

HAP Trading sold out of Editas Medicine (EDIT) in Q2 2022, closing a stake of 36,831 shares — an estimated $494K sold.

HAP Trading first reported a position in EDIT in Q1 2019 and held it in 9 quarters. The position peaked at $1.16M in Q3 2021. 256 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • HAP Trading reported no remaining Editas Medicine position as of Q2 2022 after selling out during the quarter.
  • HAP Trading sold 36,831 Editas Medicine shares in Q2 2022, an estimated $494K.
  • HAP Trading first reported a position in Editas Medicine in Q1 2019 and held it in 9 quarters.
  • HAP Trading's Editas Medicine position peaked at $1.16M in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.